^
Association details:
Biomarker:NF2 deletion
Cancer:Mesothelioma
Drug:TY-0584 (TEAD inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Source:
Title:

4491 / 16 - TY-0584: A potent, orally available small molecule YAP/TEAD inhibitor, exhibits anti-tumor effects in vitro and in vivo

Published date:
03/15/2023
Excerpt:
TY-0584 had excellent efficacy in the malignant mesothelioma H226 CDX mouse model, which is driven by NF2 deletion mutation.